CHUM
Montreal’s International Health Centre The CHUM stands out as a unique mega hospital development pole for its university academic mission, integrated care, research, teaching, technology assessment and modes of health intervention and health promotion. Written by: Stephanie C. Ocano Produced by: Cedrick Adolphe
3
C O M PA N Y N A M E
Reception
L
ocated in the heart of Quebec’s largest city, the CHUM is an international reference for academic medicine and research. Its health research center (CRCHUM) is the largest in the university network. Born from the merger of three founding hospitals (Hotel Dieu, Hopital St. Luc, and Hopital NotreDame) medical education and research has always been at the heart of its mission and vision. The hospital is now undergoing an extensive transformation towards 4
May 2015
a new teaching hospital facility and fulfilling its goal of becoming a major academic health center renowned worldwide. The redevelopment project consists of three construction phases spanning a 10 year period. It is a complex redevelopment project in the city center, near Old Montreal, and has been procured under a 34 year private-public partnership (P3) agreement. The new CHUM is a state-of-the-art academic medical center that will include 772 beds, 39 operating rooms, a cancer center,
SECTOR
a research center and an education simulation center.
promotion and evaluation of technologies—today, more than 360 researchers and almost 450 Phase 1 students contribute to the largeThe CHUM Research Centre and scale production and international Integrated Education Centre is reputation of the center. contiguous to the new health center In March 2010, the approval was complex. It would not exist without given for the construction of a new the hospital. Conversely, the CHUM research center—preceding the would not be an international construction of the new CHUM. academic medical center without In the first phase of this project, six the research and education facilities. old research centers were merged Contributing closely to the five to consolidate the expertise of both components of CHUM’s mission— researchers and students. care, teaching, research, health “The research center was built for w w w. c h u m o n t re a l . q c . c a
5
CHUM
Patient Room
$475M and was completed on time and within budget,” said Jacques Turgeon, CEO of CHUM, during a recent interview. “It has been operating since October 2013.” Encompassing 68,000 square meters, the center is one of the largest research centers in North America and one of the first to bring together under one roof a comprehensive continuum of research. Phase 2 and 3 The two subsequent phases of the project encompass the new teaching hospital facilities. The main hospital towers are scheduled 6
May 2015
to open in the Fall of 2016, and the 3rd and final phase includes a medical office building and 500 seat academic conference center. The new CHUM will replace older facilities that currently sit on three sites— Hôpital Saint-Luc, HôtelDieu and Hôpital Notre-Dame. One of the facilities—Hôpital NotreDame—will remain as a regionaltype hospital with approximately 300 beds. Together with the new CHUM hospital development there will be a total of 1,072 beds in operation upon completion. Hôtel-Dieu will likely be used as a long-term care facility in the future,
H E A LT H C A R E G L O B A L
Registration
according to Turgeon. The new CHUM is being built on the existing site of the Hôpital Saint-Luc, within a couple of meters of the existing buildings. “From a construction perspective, it’s very complex to be building so close to the existing hospital,” said Paul Landry, Project Director of the CHUM redevelopment project. “Complex construction logistics for a building that is over 3 million square feet and 22 stories in height.” The selection of the site for the new CHUM was quite strategic, according to Landry. Right beside a major highway system, the new CHUM also links to a regional train system, solving transportation issues previously encountered on the existing older sites. “We are quite pleased with the vertical scale
“We’ve gone through a very complex, very thorough, multiple years of planning” – Paul Landry
w w w. c h u m o n t re a l . q c . c a
7
ANSWERS FOR SCIENCE. KNOWLEDGE FOR LIFE.™
Enabling previously impossible research SCIEX TRIPLETOF ™ 5600 + SYSTEM
• Global quantitative proteomics with MS/MSALL with SWATH™ Acquisition • Accurate mass selectivity for regulated bioanalysis with Scheduled MRMHR and tools for compliance • Simultaneous quant and qual for metabolomics and unknown screening workflows • SelexION™ ready For an up close and personal view of the TripleTOF® System for lipidomics application, enjoy an on-demand virtual tour of the workflow at http://sciex.com/lipidomics-virtualworkshop-part-3-lab-demonstration
AB Sciex is doing business as SCIEX. © 2015 AB Sciex. For research use only. Not for use in diagnostic procedures. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB SCIEX™ is being used under license.
CHUM of the new hosptal” said Landry. “It is designed so that right from the ground floor, or even the lower levels of parking, it’s a matter of taking an elevator and going straight up to one of 35 specialty clinics or of 26 inpatient units. The patient and staff displacement is very efficient.” The third phase of the project is a doctors’ office building and a 500-seat amphitheater which sit on top of four stories of underground parking (1,350 parking spaces). The ambulatory care center encompasses the outpatient clinics with over 45 exam and treatment rooms. Prior to commencing construction
H E A LT H C A R E G L O B A L
of Phase 3, the Hôpital Saint-Luc will be demolished and Phase 3 will be built in its place. Substantial completion of Phase 3 is scheduled for March 2020. Focused Research The CHUM primarily provides care and subspecialty services to a regional and supra regional adult population. “We have identified some themes that allow us to work amongst the best researchers in the world,” said Turgeon. “So we’re very aligned with the specialties we have in our hospital population.”
w w w. c h u m o n t re a l . q c . c a
9
SUPPLIER PROFILE
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company’s global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of scientists worldwide who are focused on basic biomedical research, drug discovery and development, food and environmental testing, forensics and clinical research. Biomarker discovery is facilitated by genomics, proteomics, or metabolomics research, which promises to uncover relevant molecular targets even in the absence of detailed insight into disease mechanisms. SCIEX’s instrumentation, software, reagents, and workflows allow you to dig deeper into complex biological systems, analyze prospective biomarkers and deliver results with potential use in clinical research applications. To best serve our customer’s needs, SCIEX drives innovative solutions in accurate mass spectrometry that researchers praise for ease of use, fast data acquisition, excellent dynamic range, and accurate quantitation. For metabolomics and lipidomics studies, SCIEX has equipped CHUM’s Diabetes Research Centre Metabolomics Core Facility with high performance LC-MS quantitative instrumentation, with both accurate mass and high sensitivity measurement capabilities. The QTRAP® LC-MS system is for sensitive, targeted, quantitative metabolite assays. The high mass accuracy and resolution of the TripleTOF® LC-MS Systems allows simultaneous MS and tandem MS from a single injection for identification, confirmation, and quantitation of compounds in biological milieus. The Department of Biochemistry at CHUM’s protein and metabolite mass spectrometry laboratory, is also establishing a new leading-edge analytical facility for translational research enabled by TripleTOF® and ion mobility technologies for biomarker discovery and development. Supported by a Canadian based R&D organization, LC-MS applications scientists, and a local service team in Montreal, SCIEX honours CHUM, its research programs and faculty as a valuable partnership for accelerating the development of new analytical approaches to personalized medical care. SCIEX, a Life Science & Diagnostics under Danaher Corporation, excels by listening to and understanding the needs of our customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. This practice is shared between the Danaher family of world class brands such as Beckman Coulter, Leica Microsystems, and Molecular Devices, companies all respected for their high performance analytical instrumentation and products that deliver results for biomedical applications. For more information about SCIEX please visit www.sciex.com
CHUM
Among those specialties are oncology, breast cancer, ovarian cancer, endometrial cancer and prostate cancer. “We’re also looking at dyskinesia, or neurological diseases of the movements,” added Turgeon. “So whenever there’s a movement associated with a disease, this is what we’re looking at. We’re also looking at immunity and transplantation to make sure to have most of the major transplantation programs, such as liver, kidney,
H E A LT H C A R E G L O B A L
lungs, heart and lungs, intestine and pancreas.” Moreover, the CHUM focuses on metabolic syndromes— diabetes, Type 2 diabetes, pancreatic transplantation and insulin replacement. A Specialized Supply Chain Entirely new for the CHUM will be the implementation of an AGV system (Automated Guided Vehicles) that will transport supplies, soiled and recyclable materials throughout the 22-story hospital complex.
w w w. c h u m o n t re a l . q c . c a
11
Beckman Coulter vous remercie pour votre partenariat et félicite le CHUM pour son projet du nouveau CHUM!
We thank you for your partnership and we congratulate the CHUM on its New CHUM project!
Ensemble, nous pouvons façonner le futur du laboratoire. Avec nos approches Lean innovatrices, nous offrons les solutions dont vous avez besoin pour relever les défis auxquels votre laboratoire est confronté. Together we can shape the future of the lab. With our strategic insight and innovation, we provide the solutions you need to meet the challenges your lab faces. © Copyright 2015 Beckman Coulter, Inc. Beckman Coulter and the stylized logo are trademarks of Beckman Coulter, Inc. and are registered with the USPTO.
MOVE YOUR LAB FORWARD beckmancoulter.com
CHUM “Using dedicated elevators, approximately 70 Wi-Fi guided robotic AGVs will perform most deliveries up to the various logistics lobbies adjacent to the inpatient units” said Landry. Furthermore, the new CHUM is quite different from current supply chain functions in that the CHUM has entered into a contract with another teaching hospital in Montreal—the McGill University Health Center—for an off-site central distribution facility. “The whole supply chain has been re-planned and the AGV robots will be the transport mechanism for that
H E A LT H C A R E G L O B A L
supply chain,” added Landry. Improving Operations One of the major features in the new CHUM will be the electronic integration amongst all 772 single rooms. “We’re trying to limit infections or transmission of infection from one patient to another,” explained Turgeon. Another major feature is the stateof-the-art equipment in the 39 surgery rooms. “We will become a center for tertiary and quaternary care, which means being specialized, and ultraspecialized, in some very specific
Reception w w w. c h u m o n t re a l . q c . c a
13
Coin Viger
CHUM
diseases for better patient care.” “While this is a huge megahospital development of some 3 and a half million square feet and quite vertical, it’s also a huge transformation of the hospital’s operations,” added Landry. “We’ve gone through a very complex, very thorough, multiple years of planning—looking at our work processes, new technologies, looking at how we can become more efficient at delivering care, so you know, there’s a large focus on this massive transformation that we have to undergo to move into this new teaching hospital complex.” Communication challenges Even though the hospital will be ready to welcome its first patients in fall 2016, “we have to start communicating from now on with our patients. First of all, we have to promote the project as a major healthcare project. Secondly, we also have to reassure the patients and our employees about the transformation and the move. Since some patients will have their next appointment in more than a year, we
H E A LT H C A R E G L O B A L
have to plan ahead and find the best way to inform them as to where and when it will take place”, explained Irene Marcheterre, Communication and Information Access Director. The construction site of the new CHUM is located in downtown Montreal which is an urban district, next to Saint-Luc Hospital; therefore communication programs for the community (residents and merchants of the area) and for the medical team of the existing hospital where prepared a few years ago and are still being applied. The management of the negative or even harmful impacts (street closures, noise) had to be well planned and consider community sensitivities. “Therefore, we have special meetings for the locals twice a year where we provide information about the evolution of the project and respond – with the builder – to the questions from the public. We also plan other types of activities to facilitate our integration and to participate to the area revitalization”, said Irene Marcheterre. There are also some communication challenges w w w. c h u m o n t re a l . q c . c a
15
CHUM
16
May 2015
H E A LT H C A R E G L O B A L
related to the human resources: “each of our three hospitals has its own culture. We have to mobilize the doctors, the health workers and all the administrative employees in order to have a successful transformation”, said Irene Marcheterre. Promoting the project is important, but more importantly is to listen to staff concerns and preoccupations, she adds. What makes the new CHUM a one of kind major project is of course its architecture, well integrated to the urban fabric and the historical heritage of this district, but also its openness to art. The Quebec integration of art to the architecture policy makes sure that any public construction project allows a portion of its budget to public art. Therefore, the new CHUM will have 13 works of art (5 M$) within its walls to create a healing and calming environment.
Company Information INDUSTRY
Healthcare Global HEADQUARTERS
850 rue St. Denis Montreal, Quebec, Canada, H2X 0A9 FOUNDED
Not Disclosed EMPLOYEES
12,500 REVENUE
Looking Ahead “The major goal that I have as a CEO is to position this hospital as one of the major academic hospitals in the world, in order to be at the level of the major academic centers in the United States,” said Turgeon. “There’s so much that awaits the patients at the end of this journey,” added Landry. “There’s a lot of exciting new technology that will be available to staff and patients, but the patient care will remain at the center of our mission”. Phase 2 of construction is currently on schedule to be completed by April 2016.
$500M - $1B PRODUCTS/ SERVICES
Hospital
w w w. c h u m o n t re a l . q c . c a
17
CHUM 850 rue St. Denis Montreal, Quebec, Canada H2X 0A9 514-890-8060 www.chumontreal.qc.ca